Swedish firm InDex Pharmaceuticals Holding AB has announced that a license agreement has been signed with Viatris Pharma...
Japan-based Chugai Pharmaceutical has announced its decision to construct a new bio active pharmaceutical ingredients (A...
Japan's Meiji Seika Pharma has announced that Adcock Ingram Pharma Private, an affiliated company of Medreich has comple...
South Korea-based startup Lunit, has announced collaboration with the National Cancer Center Hospital East (NCCHE) to ev...
Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute&n...
Catalent has expanded the services and capabilities at its facility in Shiga, Japan, to include the storage, kittin...
Japan-headquartered Shimadzu Corporation as signed an agreement with Osaka University (OU) with the aim of improving the...
US-based startup KSQ Therapeutics has expanded its strategic collaboration with Japanese pharmaceutical firm Takeda to r...
A successful cyber attack can have severe consequences in healthcare, ranging from financial loss due to data breaches t...
Japanese firm Fujitsu has announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage resea...
Japan headquartered Sony Corporation and Astellas Pharma Inc. have entered into a collaborative research agree...
Using artificial intelligence (AI) to process natural language, a research group in Japan evaluated the characteristics ...
The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...
The Global Health Innovative Technology (GHIT) Fund has secured a pledge from the Bill & Melinda Gates Foundati...
Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...
Ubie Inc., a Japan-based startup, has signed a comprehensive collaboration agreement with Takeda Pharmaceutical Co. to p...
How is comprehensive genomic profiling (CGP) enhancing the quality of cancer management? Comprehensive genomic prof...
Japan headquartered Astellas Pharma Inc. and US-based Iveric Bio have entered into a definitive agreement under which As...
